Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

69.98 +0.05 (+0.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/22
Via Investor Brand Network
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/20
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Soleno Therapeutics Inc. (NASDAQ: SLNO) Climbs to New 52-Week High
Via Investor Brand Network
Forget The Magnificent 7: Did Anyone Back These 1,000% Gainers In 2023?
Baron Fifth Avenue Growth Fund gained nearly 60% over the year, while the Fidelity Blue Chip Growth ETF climbed 59%. 
Via Benzinga
Topics ETFs
4 Analysts Have This to Say About Soleno Therapeutics
Via Benzinga
Why Shares of Soleno Therapeutics Are Booming on Tuesday
Soleno announced positive top-line results for DCCR, its lead therapy. 
Via The Motley Fool
These Two Companies Surpass Nvidia, Apple And Microsoft with Astounding 1000% Returns In 2023
The two companies outperformed the 'Magnificent Seven' group of stocks, which includes tech giants such as Nvidia, Apple, and Microsoft. 
Via Benzinga
Why Soleno Therapeutics Stock Ticked Higher on Thursday
The latest pundit take on the stock provided a good reason for bulls to snap it up. 
Via The Motley Fool
Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023
These three stocks to take profits on rallied more than 200% this year. Those gains are exceedingly unlikely to repeat in 2024. 
Via InvestorPlace
3 Stock Winners That Are Up 500% or More in 2023
If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January 
Via InvestorPlace
7 Stock Winners That Are Up 1,000% or More in 2023
Could any or all of these seven stocks up 1000% this year go on another hot run during 2024? Let's find out. 
Via InvestorPlace
5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains
These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent. 
Via InvestorPlace
Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.
When investors land on a "jackpot" stock, gains can offset even the steepest losses. Here are the top stocks to buy if you're feeling lucky. 
Via InvestorPlace
3 Biotech Stocks With Big-Time Breakthrough Potential
The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave. 
Via InvestorPlace
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA
Some big 2023 winners are shorted heavily, including two AI plays. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top 5 Health Care Stocks That May Plunge In October
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
Soleno Therapeutics is working on a treatment for Prader Willi syndrome, a genetic disease that causes obesity. 
Via Investor's Business Daily
Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus. 
Via Investor's Business Daily
Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Dow Jones gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Shares of Soleno Therapeutics Dropped on Wednesday
Investors took profits a day after the clinical-stage biotech company's shares soared. 
Via The Motley Fool
Don’t Miss the Boom: 3 ETFs Set to Explode Higher
The market may be uncertain. But these three ETFs to buy are set to deliver fantastic returns regardless of the broader economic climate. 
Via InvestorPlace
Topics ETFs
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Shares of Soleno Therapeutics (NASDAQ: SLNO) Surge Over 500% After Its DCCR Candidate Shows Promise in PWS Clinical Trials
Breakthrough Results from Study C602 Soleno Therapeutics, Inc. (NASDAQ: SLNO), a trailblazer in the biopharmaceutical industry, recently unveiled its promising 
Via Spotlight Growth
Exposures Product Safety
Soleno Therapeutics' Study Outcome Bolsters Confidence In PWS Treatment
Earlier on Tuesday, Soleno Therapeutics Inc (NASDAQ: SLNO) released top-line results from the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide Choline)... 
Via Benzinga
Nasdaq Down 1.5%; Immunovant Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601.60 while the NASDAQ fell 1.48% to 13,074.97. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.